CLINICAL_TRIALS
trial_result
· 2009-10-15
Clinical Trial Update: Safety and Efficacy of SPD503 in Treating ADHD in Children and Adolescents Aged 6-17 [Phase 3]
Summary
Phase 3 trial update on SPD503 for ADHD in children and adolescents shows results and completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shire | Conditions: Attention Deficit Disorder With Hyperactivity | Phase 3 | Status: COMPLETED | Results posted: 2009-10-15